Spots Global Cancer Trial Database for patient preference
Every month we try and update this database with for patient preference cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer | NCT05415215 | Early Breast Ca... Locally Advance... Inflammatory Br... | Fixed Dose Comb... Pertuzumab IV Trastuzumab IV Trastuzumab Emt... Investigator's ... Surgery Radiotherapy | 18 Years - | Hoffmann-La Roche | |
| TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance) | NCT04936243 | Breast Cancer Prostate Cancer Patient Engagem... Patient Prefere... Patient Satisfa... | FOLLOW UP VISIT... FOLLOW UP VISIT... | 18 Years - | Dana-Farber Cancer Institute | |
| Tradeoffs in Patient Decision Making About Rectal Cancer Treatment: Benefits Compared to Quality Of Life. | NCT04925154 | Patient Prefere... | The only interv... | 18 Years - | Sir Mortimer B. Davis - Jewish General Hospital | |
| Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer | NCT04409288 | Prostate Cancer | Apalutamide Enzalutamide | 18 Years - | Chinese University of Hong Kong | |
| A Study of Adjuvant Melanoma Stakeholder Treatment Preferences | NCT05115006 | Melanoma | 18 Years - | Bristol-Myers Squibb | ||
| To Better Understand the Most Important Factors for Patients When They Decide on the Type of Treatment They Receive for Muscle Invasive Bladder Cancer (MIBC). | NCT05236218 | Muscle Invasive... Surgery Sexual Wellbein... Patient Satisfa... Patient Prefere... | Discrete Choice... Semi-Structured... | 18 Years - | King's College London | |
| Tradeoffs in Patient Decision Making About Rectal Cancer Treatment: Benefits Compared to Quality Of Life. | NCT04925154 | Patient Prefere... | The only interv... | 18 Years - | Sir Mortimer B. Davis - Jewish General Hospital | |
| Nasal Fentanyl for Chronic Cancer Pain | NCT01906073 | Cancer Pain | intranasal fent... slow release mo... | 18 Years - | Norwegian University of Science and Technology | |
| Oral Epithelial Dysplasia Informational Needs Questionnaire | NCT04153266 | Oral Epithelial... Precancerous Co... Precancerous Le... Oral Lichen Pla... Oral Leukoplaki... Oral Leukoplaki... Oral Leukoplaki... Oral Leukoplaki... Oral Erythropla... Chronic Hyperpl... Oral Submucous ... Oral Submucosal... Oral Disease Dental Diseases Dysplasia Information See... Patient Prefere... Information Nee... Health Behavior Quality of Life Preference, Pat... Patient Satisfa... Patient Engagem... Patient Partici... | No intervention... | 18 Years - | University College, London | |
| Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer | NCT01064310 | Carcinoma, Rena... | pazopanib sunitinib | 18 Years - | Novartis | |
| Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer | NCT01064310 | Carcinoma, Rena... | pazopanib sunitinib | 18 Years - | Novartis | |
| Non-interventional Study to Evaluate Patient and Healthcare Provider Satisfaction of Daratumumab Use in the Treatment of First-line Daratumumab, Lenalidomide, Dexamethasone (DRd) Multiple Myeloma Patients in Germany Depending on Application Route (sc or iv) | NCT05284591 | Multiple Myelom... Newly Diagnosed Transplant Inel... Patient Satisfa... Patient Prefere... Personal Satisf... | Daratumumab | 18 Years - | iOMEDICO AG | |
| TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance) | NCT04936243 | Breast Cancer Prostate Cancer Patient Engagem... Patient Prefere... Patient Satisfa... | FOLLOW UP VISIT... FOLLOW UP VISIT... | 18 Years - | Dana-Farber Cancer Institute | |
| A Study of Adjuvant Melanoma Stakeholder Treatment Preferences | NCT05115006 | Melanoma | 18 Years - | Bristol-Myers Squibb | ||
| An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy | NCT00721981 | Lung Cancer Non-small Cell ... | 18 Years - | AstraZeneca | ||
| Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment | NCT05618912 | Scar Skin Scarring Skin Cancer Wound Heal Wound of Skin Surgical Wound Patient Satisfa... Patient Prefere... Surgical Incisi... | Hydrocolloid dr... Petrolatum jell... | 18 Years - | Indiana University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
